References
- Stefánson T, Ekbom A, Spàrèn P, Påhlman L. The association between sigmoid diverticulitis and left-sided colon cancer. A nested population-based case control study. Scand J Gastroenterol 2004;39:743–7.
- Stefánson T, Ekbom A, Spàrèn P, Påhlman L. Increased risk of left-sided colon cancer in patients with diverticular disease. Gut 1993;34:499–502.
- Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998;115:281–6.
- Singh V, Kumar P, Kamal J, Prakash K, Vaiphei K, Singh K. Clinicocolonoscopic profile of colonic tuberculosis. Am J Gastroenterol 1996;91:565–8.
- Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585–90.
- Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomised trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891–9.
- Steinbach G, Lynch P, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatosis polyposis. N Engl J Med 2000;342:1946–52.
- Lynge E. Recommendations on cancer screening in the European Union. Advisory committee on cancer prevention. Eur J Cancer 2000;36:1473–8.
- Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH, et al. Faecal calprotectin levels in high risk population for colorectal neoplasia. GUT 2000;46:795–800.